Notable
SOLVE-CRT · Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
Primary and study completion pushed from Jun 2026 to Nov 2027
EBR Systems, Inc.Not applicable NCT02922036 Registry history of NCT02922036 on ClinicalTrials.gov (opens the registry)